meta_pixel
Tapesearch Logo
Log in
Raising Parents with Emily Oster

Ep 3: Are We Feeding Kids the Wrong Foods?

Raising Parents with Emily Oster

The Free Press

Parenting, Kids & Family

4.5 • 660 Ratings

🗓️ 2 October 2024

⏱️ 60 minutes

🧾️ Download transcript

Summary

In January 2023, the American Academy of Pediatrics surprised doctors and parents by changing its guidelines on treating childhood obesity to include the use of popular weight-loss drugs like Ozempic and Wegovy, also known as semaglutide, for children ages 12 years or older. And parents all over the country were faced with yet another difficult decision: Should I consider a lifelong weight-loss drug for my 12-year-old? The fact that this is even on the table at all is a pretty shocking indictment of the state of our kids’ health. Nearly 20 percent of American children and adolescents are obese, a 300 percent increase since the 1970s. Meanwhile, a little over 42 percent of American adults are obese, a 180 percent increase since the 1970s. The United States ranks 12th worldwide in obesity prevalence. This places the U.S. among the countries with the highest obesity rates in the world. The question is: Why? And why haven’t we been able to reduce childhood obesity rates?  As obesity rates have skyrocketed, we as a society have also changed the way we talk about weight and obesity. Yes, there is less stigma today about weight—which is good. But people—including health experts—have stopped speaking out loud about the real health risks of obesity. Take, for example, how during the pandemic our health leaders wouldn’t tell the public that obesity is a high risk factor for contracting Covid, out of a presumed fear of stigmatizing obese people. In the end, all of this has led to confusion about the real health risks of obesity. Parents, in particular, are left to struggle with how to navigate food and health for their children. They may be left wondering whether the entire idea of a link between weight and health may simply be misinformation. So today, we’re setting the table: Why Is childhood obesity such a big problem in the U.S.? Why is obesity problematic in the first place? What will it take to change the way Americans feed our children? And what’s at stake if we don’t? *** Resources from this episode: Pamela Druckerman: Bringing Up Bébé: One American Mother Discovers the Wisdom of French Parenting  Robert Lustig: “The Hacking of the American Mind: The Science Behind the Corporate Takeover of Our Bodies and Brains”  Robert J. Davis: “Supersized Lies: How Myths about Weight Loss Are Keeping Us Fat — and the Truth about What Really Works”  FoodCorps Sam Kass Curt Ellis

Transcript

Click on a timestamp to play from that location

0:00.0

Hi, everyone. Emily here, and you're listening to Raising Parents, my new podcast in partnership with

0:06.0

the free press, where we interrogate all of the big and pressing and confusing questions facing

0:11.6

parents today. Before we get to the show, I'm so excited to tell you that this season is in partnership

0:17.3

with Airbnb. If you know anything about me, you know how much I love Airbnb.

0:22.4

I think I'm currently holding like six Airbnb reservations in my account.

0:27.4

Airbnb has provided incredible experiences for me, my family, and our friends across the

0:33.0

country and the world time and time again.

0:36.3

More on that and how you too can use Airbnb on your next

0:39.9

family trip later in the episode. For now, on to the show. We govi helped us lose weight.

0:48.0

And Manjaro can help decrease how much food you eat. Drugs for weight loss now being prescribed to kids as young as 12, and last year, at least

0:56.8

4,000 prescriptions of somaglite.

0:59.5

The active ingredient in Ozempic and Wagovi were dispensed to patients ages 12 to 17,

1:05.3

that number expected to grow.

1:07.0

Somaglite drugs like Ozempic and Wagovi are seeing a boom and they're not just being used by adults.

1:12.7

America's too fat. You know this. Our kids too. So the FDA has approved the weight loss drug Wagovi, sister to OZempec, for kids 12 and up. What should doctors do? Should your teen be on this?

1:25.6

In January, 2023, the American Academy of Pediatrics, the AAP, surprised doctors and parents

1:34.1

around the country by changing its guidelines on treating childhood obesity to include the

1:40.1

use of popular weight loss drugs like OZempec and Wagovi, also known as Simaglutide,

1:47.1

for children ages 12 or older. And parents all over the country were faced with yet another

1:53.3

difficult decision. Should I consider a lifelong weight loss drug for my 12-year-old?

2:00.1

The fact that this is even on the table at all is a pretty shocking indictment about the state of our kids' health.

2:06.2

Nearly 20% of American children and adolescents are obese, a 300% increase since the 1970s.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Free Press, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Free Press and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.